Amedeo Smart

Free Medical Literature Service

 

Amedeo

Nuclear Medicine
  Free Subscription

Articles published in
Brain
    June 2026
  1. XIN JW, Wang ZY, Guo Y, Chen KL, et al
    Diagnostic impact of tau versus amyloid PET in patients with cognitive symptoms.
    Brain. 2026 Jun 20:awag207. doi: 10.1093.
    >> Share

  2. WISCH JK, Jiao Z, Kennedy JT, Cohen AD, et al
    Imaging and plasma biomarkers for pathological accumulation in Down syndrome.
    Brain. 2026;149:1944-1957.
    >> Share

  3. DE MARCHI F, Baj A, Menegon F, Caminiti SP, et al
    Profiling cognition and brain metabolism in amyotrophic lateral sclerosis and frontotemporal dementia.
    Brain. 2026;149:2046-2058.
    >> Share

    May 2026
  4. DI PEDE F, Cabras S, Manera U, Vasta R, et al
    King's stages of amyotrophic lateral sclerosis: an 18F-FDG-PET study of brain connectivity.
    Brain. 2026 May 8:awag159. doi: 10.1093.
    >> Share

    April 2026
  5. COOMANS EM, Smith R, Pawlik D, Oliveira Hauer K, et al
    Neuropathological correlates of age and sex differences in 18F-flortaucipir PET.
    Brain. 2026 Apr 20:awag136. doi: 10.1093.
    >> Share

  6. BENINA N, Buitrago L, De Simone FI, Radwan RR, et al
    Plasma pTau 217/beta-amyloid 1-42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology.
    Brain. 2026;149:1168-1181.
    >> Share

  7. MANASOVA D, Belloli LML, Rosenfelder MJ, Willacker L, et al
    Multimodal multicentre investigation of diagnostic and prognostic markers in disorders of consciousness.
    Brain. 2026;149:1381-1395.
    >> Share

    March 2026
  8. CORAZZOLLA G, Treaba CA, Mohammadian M, Brusaferri L, et al
    Evidence of skull bone translocator protein overexpression linked to multiple sclerosis progression.
    Brain. 2026 Mar 9:awag084. doi: 10.1093.
    >> Share

    February 2026
  9. COGSWELL PM, Lundt ES, Therneau TM, Hu M, et al
    Modelling the temporal evolution of plasma p-tau217, amyloid PET, tau PET and cognition.
    Brain. 2026 Feb 25:awag075. doi: 10.1093.
    >> Share

  10. MIZUNO Y, Carreira Figueiredo I, Pillinger T, Hindley G, et al
    Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study.
    Brain. 2026;149:620-631.
    >> Share

  11. CHIARO G, Vichayanrat E, Koay S, Rogeau A, et al
    Pure autonomic failure: a natural history study of the Queen Square cohort.
    Brain. 2026;149:606-619.
    >> Share

    January 2026
  12. TRUDEL L, Therriault J, Macedo AC, Hosseini SA, et al
    Clinical-biological Alzheimer's disease stage concordance: insights from cohorts and autopsy data.
    Brain. 2026 Jan 20:awag018. doi: 10.1093.
    >> Share

  13. KALINOWSKI A, Steinman L
    The complexity of interpreting TSPO PET neuroimaging in first-episode psychosis.
    Brain. 2026 Jan 8:awaf476. doi: 10.1093.
    >> Share

    December 2025
  14. STEWARD A, Dewenter A, Hirsch F, Roemer-Cassiano SN, et al
    ApoE4 lowers the ptau217 threshold for tau aggregation and spread in an allele dose-dependent manner.
    Brain. 2025 Dec 18:awaf463. doi: 10.1093.
    >> Share

  15. ZHU GH, He R, Yang ZY, Wang TT, et al
    Compensatory roles of STT3A and ALG5 in glucose metabolism of aged macaque hippocampus.
    Brain. 2025;148:4416-4434.
    >> Share

  16. HVINGELBY VS, Terkelsen MH, Johnsen EL, Moller M, et al
    Cholinergic patterns correlate with dopamine medication ON freezing of gait in Parkinson's disease.
    Brain. 2025;148:4508-4518.
    >> Share

    November 2025
  17. ZAMMIT MD, Bruzzone H, Cody KA, Morse J, et al
    The tau biomarker cascade is condensed in Down syndrome compared to sporadic Alzheimer's disease.
    Brain. 2025 Nov 15:awaf428. doi: 10.1093.
    >> Share

  18. LUAN Y, Huang Q, Wang J, Guan Y, et al
    Synaptic density and tau pathology in Alzheimer's disease: a dual role in susceptibility and degeneration.
    Brain. 2025 Nov 13:awaf425. doi: 10.1093.
    >> Share

  19. LI LL, Wang RZ, Wang Z, Hu H, et al
    Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.
    Brain. 2025 Nov 11:awaf427. doi: 10.1093.
    >> Share

  20. KIM R, Jin B, Kim H, Woo KA, et al
    Cholinergic basal forebrain degeneration in isolated REM sleep behaviour disorder.
    Brain. 2025;148:4084-4097.
    >> Share

  21. RAKET LL, Pichet Binette A, Mattsson-Carlgren N, Janelidze S, et al
    Estimating the time course of biomarker changes in Alzheimer's disease.
    Brain. 2025 Nov 3:awaf413. doi: 10.1093.
    >> Share

    October 2025
  22. ALBORNOZ EA, Mardon K, Bhalla R, Kumar V, et al
    PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease models.
    Brain. 2025 Oct 16:awaf372. doi: 10.1093.
    >> Share

  23. ALEXANDERSEN CG, Bassett DS, Goriely A, Chaggar P, et al
    Neuronal activity and amyloid-beta promote tau seeding in the entorhinal cortex in Alzheimer's disease.
    Brain. 2025 Oct 7:awaf374. doi: 10.1093.
    >> Share

  24. KARLSSON L, Janelidze S, Barthelemy NR, Horie K, et al
    Reference proteins to improve Core 1 and Core 2 Alzheimer's disease CSF and plasma biomarkers.
    Brain. 2025 Oct 6:awaf375. doi: 10.1093.
    >> Share

    September 2025
  25. JOHNSON DR, Wiste HJ, Lowe V, Schwarz CG, et al
    Staging Alzheimer's disease through amyloid and tau PET.
    Brain. 2025 Sep 19:awaf346. doi: 10.1093.
    >> Share

  26. PESCOLLER J, Dewenter A, Dehsarvi A, Steward A, et al
    Cortical tau deposition promotes atrophy in connected white matter regions in Alzheimer's disease.
    Brain. 2025 Sep 12:awaf339. doi: 10.1093.
    >> Share

    August 2025
  27. DE BRUIN H, Groot C, Barthel H, Bischof GN, et al
    Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease.
    Brain. 2025 Aug 14:awaf279. doi: 10.1093.
    >> Share

    July 2025
  28. ANAND C, Abdelnour F, Sipes B, Ma D, et al
    Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome.
    Brain. 2025 Jul 9:awaf179. doi: 10.1093.
    >> Share

  29. KAZAZIAN K, Monti MM, Owen AM
    Functional neuroimaging in disorders of consciousness: towards clinical implementation.
    Brain. 2025;148:2283-2298.
    >> Share

  30. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Zhang L, Castro-Labrador S, et al
    The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients.
    Brain. 2025;148:2441-2452.
    >> Share

  31. CICOGNOLA C, Salvado G, Smith R, Palmqvist S, et al
    APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta.
    Brain. 2025;148:2373-2383.
    >> Share

    June 2025
  32. PRANGE S, Metereau E, Klinger H, Huddlestone M, et al
    Serotonergic dysfunction in patients with impulse control disorders in Parkinson's disease.
    Brain. 2025;148:2108-2121.
    >> Share

    May 2025
  33. KOCH PJ, Frey BM, Backhaus W, Petersen N, et al
    Neurotransmitter-informed connectivity maps and their application for outcome inference after stroke.
    Brain. 2025 May 20:awaf185. doi: 10.1093.
    >> Share

  34. HONG H, Tozer DJ, Chen Y, Brown RB, et al
    Perivascular space dysfunction in cerebral small vessel disease is related to neuroinflammation.
    Brain. 2025;148:1540-1550.
    >> Share

    April 2025
  35. LU K, Baker J, Nicholas JM, Street RE, et al
    Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults.
    Brain. 2025;148:1302-1315.
    >> Share

    February 2025
  36. WIJESINGHE SS, Rowe JB, Mason HD, Allinson KSJ, et al
    Post-mortem validation of in vivo TSPO PET as a microglial biomarker.
    Brain. 2025 Feb 26:awaf078. doi: 10.1093.
    >> Share

  37. EIFF B, Bullmore ET, Clatworthy MR, Fryer TD, et al
    Extra-axial inflammatory signal and its relationship to peripheral and central immunity in depression.
    Brain. 2025;148:635-646.
    >> Share

  38. WARMENHOVEN N, Salvado G, Janelidze S, Mattsson-Carlgren N, et al
    A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests.
    Brain. 2025;148:416-431.
    >> Share

  39. MALPETTI M, Swann P, Tsvetanov KA, Chouliaras L, et al
    Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration.
    Brain. 2025;148:493-505.
    >> Share

    January 2025
  40. FERNANDEZ ARIAS J, Brum WS, Salvado G, Therriault J, et al
    Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrum.
    Brain. 2025 Jan 29:awaf033. doi: 10.1093.
    >> Share

  41. TOHYAMA S, Datko M, Brusaferri L, Kinder LD, et al
    Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine.
    Brain. 2025 Jan 28:awaf029. doi: 10.1093.
    >> Share

  42. SAINBURG LE, Englot DJ, Morgan VL
    The impact of resective epilepsy surgery on the brain network: evidence from post-surgical imaging.
    Brain. 2025 Jan 24:awaf026. doi: 10.1093.
    >> Share

  43. CHAUVEAU L, Landeau B, Dautricourt S, Turpin AL, et al
    Anterior-temporal network hyperconnectivity is key to Alzheimer's disease: from ageing to dementia.
    Brain. 2025 Jan 15:awaf008. doi: 10.1093.
    >> Share

  44. WIMBERLEY C, Thompson G
    Bridging peripheral and central inflammation with TSPO-PET: insights into depression and beyond.
    Brain. 2025 Jan 9:awae403. doi: 10.1093.
    >> Share

    November 2024
  45. DUONG MT, Das SR, Khandelwal P, Lyu X, et al
    Hypometabolic mismatch with atrophy and tau pathology in mixed Alzheimer and Lewy body disease.
    Brain. 2024 Nov 22:awae352. doi: 10.1093.
    >> Share

  46. SAKATO Y, Shima A, Terada Y, Takeda K, et al
    Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson's disease.
    Brain. 2024;147:3702-3713.
    >> Share

  47. SPITZ G, Hicks AJ, McDonald SJ, Dore V, et al
    Plasma biomarkers in chronic single moderate-severe traumatic brain injury.
    Brain. 2024;147:3690-3701.
    >> Share

    October 2024
  48. KATSUMI Y, Howe IA, Eckbo R, Wong B, et al
    Default mode network tau predicts future clinical decline in atypical early Alzheimer's disease.
    Brain. 2024 Oct 16:awae327. doi: 10.1093.
    >> Share

  49. BANWINKLER M, Dzialas V, Rigoux L, Asendorf AL, et al
    Putaminal dopamine modulates movement motivation in Parkinson's disease.
    Brain. 2024;147:3352-3357.
    >> Share

  50. D'ANGREMONT E, van der Zee S, Slingerland S, Slomp AC, et al
    Cholinergic deficiency in Parkinson's disease patients with visual hallucinations.
    Brain. 2024;147:3370-3378.
    >> Share

    September 2024
  51. ABANTO J, Dwivedi AK, Imbimbo BP, Espay AJ, et al
    Increases in amyloid-beta42 slow cognitive and clinical decline in Alzheimer's disease trials.
    Brain. 2024 Sep 11:awae216. doi: 10.1093.
    >> Share

    July 2024
  52. APPLETON J, Finn Q, Zanotti-Fregonara P, Yu M, et al
    Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer's disease.
    Brain. 2024 Jul 16:awae234. doi: 10.1093.
    >> Share

  53. DEVULDER A, Vanderlinden G, Van Langenhoven L, Testelmans D, et al
    Epileptic activity on foramen ovale electrodes is associated with sleep and tau pathology in Alzheimer's disease.
    Brain. 2024 Jul 11:awae231. doi: 10.1093.
    >> Share

  54. NILSSON J, Pichet Binette A, Palmqvist S, Brum WS, et al
    Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases.
    Brain. 2024;147:2414-2427.
    >> Share

    June 2024
  55. PERETTI DE, Boccalini C, Ribaldi F, Scheffler M, et al
    Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline.
    Brain. 2024 Jun 28:awae211. doi: 10.1093.
    >> Share

  56. ROEMER SN, Brendel M, Gnoerich J, Malpetti M, et al
    Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies.
    Brain. 2024 Jun 6:awae174. doi: 10.1093.
    >> Share

    May 2024
  57. ALTMANN A, Aksman LM, Oxtoby NP, Young A, et al
    Towards cascading genetic risk in Alzheimer's disease.
    Brain. 2024 May 31:awae176. doi: 10.1093.
    >> Share

  58. TETZLOFF KA, Martin PR, Duffy JR, Utianski RL, et al
    Longitudinal flortaucipir, metabolism and volume differ between phonetic and prosodic speech apraxia.
    Brain. 2024;147:1696-1709.
    >> Share

  59. CROWLEY SJ, Kanel P, Roytman S, Bohnen NI, et al
    Basal forebrain integrity, cholinergic innervation and cognition in idiopathic Parkinson's disease.
    Brain. 2024;147:1799-1808.
    >> Share

    April 2024
  60. CODY KA, Langhough RE, Zammit MD, Clark L, et al
    Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.
    Brain. 2024 Apr 26:awae116. doi: 10.1093.
    >> Share

  61. WANG YT, Therriault J, Servaes S, Tissot C, et al
    Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster tangle accumulation in females.
    Brain. 2024;147:1497-1510.
    >> Share

    March 2024
  62. DE MEYER S, Blujdea ER, Schaeverbeke J, Reinartz M, et al
    Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.
    Brain. 2024;147:936-948.
    >> Share

    February 2024
  63. YANG HS, Yau WW, Carlyle BC, Trombetta BA, et al
    Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
    Brain. 2024 Feb 5:awae034. doi: 10.1093.
    >> Share

    January 2024
  64. HERRANZ E, Treaba CA, Barletta VT, Mehndiratta A, et al
    Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
    Brain. 2024 Jan 30:awae030. doi: 10.1093.
    >> Share

  65. BAGNATO F, Sati P, Hemond CC, Elliott C, et al
    Imaging chronic active lesions in multiple sclerosis: a consensus statement.
    Brain. 2024 Jan 16:awae013. doi: 10.1093.
    >> Share

    December 2023
  66. SCHUMACHER J, Kanel P, Dyrba M, Storch A, et al
    Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.
    Brain. 2023;146:4964-4973.
    >> Share

    November 2023
  67. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Moscoso A, Scholl M, et al
    Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Brain. 2023;146:4520-4531.
    >> Share

    October 2023
  68. LAURENCIN C, Lancelot S, Brosse S, Merida I, et al
    Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study.
    Brain. 2023 Oct 3:awad338. doi: 10.1093.
    >> Share

    September 2023
  69. BOCANCEA DI, Svenningsson AL, van Loenhoud AC, Groot C, et al
    Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
    Brain. 2023;146:3719-3734.
    >> Share

  70. COOMANS EM, Tomassen J, Ossenkoppele R, Tijms BM, et al
    Genetically identical twin-pair difference models support the amyloid cascade hypothesis.
    Brain. 2023;146:3735-3746.
    >> Share

    July 2023
  71. AKSMAN LM, Oxtoby NP, Scelsi MA, Wijeratne PA, et al
    A data-driven study of Alzheimer's disease related amyloid and tau pathology progression.
    Brain. 2023 Jul 11:awad232. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016